Skip to main content

Advertisement

SpringerLink
Log in

The number of CD34+CD133+ hematopoietic stem cells residing in umbilical cord blood (UCB) units is not correlated with the numbers of total nucleated cells and CD34+ cells: a possible new indicator for quality evaluation of UCB units

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Umbilical cord blood transplantation (UCBT) is often associated with delayed neutrophil and platelet recovery. Engraftment failure is another major obstacle. Several factors influence these serious complications, including the numbers of total nucleated cells (TNCs) and CD34+ cells which have been used as reliable factors for selecting UCB units for transplantation. However, whether both factors are reliable indices of the hematopoietic stem cell (HSC) activity of UCB units remains unknown. To evaluate the quality of UCB units, we quantified the actual number of transplantable CD34+CD133+ HSCs (tHSCs) residing in UCB units. The number of tHSCs was not correlated with the numbers of TNCs or CD34+ cells. These results strongly suggest that neither factor reflects the numbers of tHSCs residing in UCB units. To validate the significance of the number of tHSCs, further analysis is required to determine whether the number of tHSCs residing in UCB units is useful as a new indicator for the quality assessment of UCB units.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174–8.

    Article  CAS  Google Scholar 

  2. Gluckman E, Ruggeri A, Volt F, Cunha R, Boudjedir K, Rocha V. Milestones in umbilical cord blood transplantation. Br J Haematol. 2011;154:441–7.

    Article  Google Scholar 

  3. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122:491–8.

    Article  CAS  Google Scholar 

  4. Metheny L, Caimi P, de Lima M. Cord blood transplantation: can we make it better? Front Oncol. 2013;3:238.

    Article  Google Scholar 

  5. Kerke N, Antin JH. Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. Blood. 2014;124:334–43.

    Article  Google Scholar 

  6. Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, et al. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transpl. 2010;16:1099–106.

    Article  Google Scholar 

  7. Satwani P, Jin Z, Duffy D, Morris E, Bhatia M, Garvin JH, et al. Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients. Biol Blood Marrow Transpl. 2013;19:552–615.

    Article  Google Scholar 

  8. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–8.

    CAS  PubMed  Google Scholar 

  9. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815–22.

    Article  CAS  Google Scholar 

  10. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcomes among 562 recipients of placenta-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–77.

    Article  CAS  Google Scholar 

  11. Matsuno N, Wake A, Uchida N, Ishiwata K, Araoka H, Takagi S, et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood. 2009;114:1689–95.

    Article  CAS  Google Scholar 

  12. Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood. 2010;115:1843–9.

    Article  CAS  Google Scholar 

  13. Krause DS, Fackler MJ, Civin CI, May WS. CD34: Structure, biology, and clinical utility. Blood. 1996;87:1–13.

    CAS  PubMed  Google Scholar 

  14. Radtke S, Görgens A, Kordelas L, Schmidt M, Kimmig KR, Köninger A, et al. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants. Br J Haematol. 2015;169:868–78.

    Article  CAS  Google Scholar 

  15. Theilgaard-Mönch K, Raaschou-Jensen K, Palm H, Schjødt K, Heilmann C, Vindeløv L, et al. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transpl. 2001;28:1073–82.

    Article  Google Scholar 

  16. Takahashi M, Matsuoka Y, Sumide K, Nakatsuka R, Fujioka T, Kohno H, et al. CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34–negative hematopoietic stem cells. Leukemia. 2014;28:1308–15.

    Article  CAS  Google Scholar 

  17. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guideline for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–26.

    Article  CAS  Google Scholar 

  18. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100:3175–82.

    Article  CAS  Google Scholar 

  19. Wang J, Kimura T, Asada R, Harada S, Yokota S, Kawamoto Y, et al. SCID-repopulating cell activity of human cord blood-derived CD34− cells assured by intra-bone marrow injection. Blood. 2003;101:2924–31.

    Article  CAS  Google Scholar 

  20. Matsuoka Y, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, Sonoda Y. GPI-80 expression highly purifies human cord blood-derived primitive CD34-negative hematopoietic stem cells. Blood. 2016;128:2258–60.

    Article  CAS  Google Scholar 

  21. Kimura T, Asada R, Wang J, Kimura T, Morioka M, Matsui K, et al. Identification of long-term repopulating potential of human cord blood-derived CD34–flt3– severe combined immunodeficiency-repopulating cells by intra-bone marrow injection. Stem Cells. 2007;25:1348–55.

    Article  CAS  Google Scholar 

  22. Kimura T, Matsuoka Y, Murakami M, Kimura T, Takahashi M, Nakamoto T, et al. In vivo dynamics of human cord blood-derived CD34– SCID-repopulating cells using intra-bone marrow injection. Leukemia. 2010;24:162–8.

    Article  CAS  Google Scholar 

  23. Hu Y, Smyth GK. ELDA. Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347:70–8.

    Article  CAS  Google Scholar 

  24. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–75.

    Article  CAS  Google Scholar 

  25. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.

    Article  CAS  Google Scholar 

  26. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, et al. Effect of graft source on unrelated donor haematopoietic stem-cell transplantation in adults with acute leukemia: a retrospective analysis. Lancet Oncol. 2010;11:653–60.

    Article  Google Scholar 

  27. Martin PS, Li S, Nikiforow S, Alyea EP 3rd, Antin JH, Armand P, et al. Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation. Haematologica. 2016;101:499–505.

    Article  CAS  Google Scholar 

  28. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000;96:2717–22.

    CAS  PubMed  Google Scholar 

  29. Page KM, Zhang L, Mendizabal A, Wease S, Carter S, Gentry T, et al. Total colony-forming units are strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants. Biol Blood Marrow Transpl. 2011;17:1362–74.

    Article  Google Scholar 

  30. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood. 2004;104:3813–20.

    Article  CAS  Google Scholar 

  31. Atsuta Y. Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol. 2016;103:3–10.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan. The authors are grateful to the Japanese Red Cross Kinki Cord Blood Bank for providing the CB samples used in this study. Drs. S. Nomura, S. Fujita, H. Ogawa, M. Inoue and H. Nakamae are acknowledged for their valuable contribution to this study.

Author information

Authors and Affiliations

  1. Department of Stem Cell Biology and Regenerative Medicine, Graduate School of Medical Science, Kansai Medical University, Hirakata, Osaka, 573-1010, Japan

    Yoshikazu Matsuoka, Tatsuya Fujioka & Yoshiaki Sonoda

  2. Clinical Development and Operations, Product Development Department, Bayer Yakuhin, Ltd, Osaka, Japan

    Fumiaki Nakamura

  3. Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan

    Kazuo Hatanaka

  4. Japanese Red Cross Kinki Block Blood Center, Osaka, Japan

    Satoshi Otani, Takafumi Kimura & Yoshihiro Fujimura

  5. Graduate School of Nursing for Health Care Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

    Hiroaki Asano

Authors
  1. Yoshikazu Matsuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fumiaki Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuo Hatanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tatsuya Fujioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Satoshi Otani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takafumi Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoshihiro Fujimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroaki Asano
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yoshiaki Sonoda
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YM, designed and performed a majority of the experiments, analyzed and interpreted the data; FN, KH, TF, contributed to the data analysis and interpretation; SO, TK, YF, designed and performed some of the experiments, analyzed and interpreted the data; HA, provided advice on the statistical analyses; YS, conceived of and designed the study, analyzed and interpreted the data, provided financial and administrative support, and wrote the paper.

Corresponding author

Correspondence to Yoshiaki Sonoda.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 71 KB)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsuoka, Y., Nakamura, F., Hatanaka, K. et al. The number of CD34+CD133+ hematopoietic stem cells residing in umbilical cord blood (UCB) units is not correlated with the numbers of total nucleated cells and CD34+ cells: a possible new indicator for quality evaluation of UCB units. Int J Hematol 108, 571–579 (2018). https://doi.org/10.1007/s12185-018-2502-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-018-2502-7

Keywords

Search

Navigation